GISAID EpiCoV and EpiFlu
GISAID (Freunde von GISAID e.V.)
The largest pool of SARS-CoV-2 and flu genomes, open only to registered users who sign its terms.
GISAID hosts virus genome sequences with collection date, location, and lab metadata for SARS-CoV-2 (EpiCoV), influenza (EpiFlu), and other pathogens. It became the main channel for COVID genomic surveillance, holding many millions of SARS-CoV-2 genomes. Access requires an identified account and a database access agreement that bars redistribution and requires crediting the labs that generated the data.
Access
- Cost
- By applicationNo fee, but users must register with verified identity and accept the GISAID Database Access Agreement; data may not be redistributed.
- License
- Provider's own termsGISAID Database Access Agreement
- Sign-up
- Application required
- How you get it
- Bulk downloadFASTA, TSV metadata
What's in it
- One row is
- One record per virus genome sequence
- Covers
- Submissions from labs in most countries
- Years
- 2008-present (EpiFlu); 2020-present (EpiCoV)
- Updated
- Daily
- Size
- Many millions of SARS-CoV-2 genomes plus influenza and other pathogens
Quality
Unmatched volume and speed for flu and COVID surveillance. Sampling reflects which countries sequence, and terms make reproducible sharing harder than open archives.
- Huge geographic imbalance in sequencing effort
- Redistribution barred, complicating reproducibility
- Governance has been publicly disputed
Connects to
- Nextstrain: Builds phylogenies from GISAID and GenBank sequences
- GenBank: Open-access alternative holding a subset of the same virus genomes
Questions it could answer
- How quickly did each new SARS-CoV-2 variant reach different continents?
- Which countries sequenced the largest share of their reported cases?